Publicaciones en colaboración con investigadores/as de University Hospital of Lausanne (24)

2024

  1. Development of the PSYCHS: Positive SYmptoms and Diagnostic Criteria for the CAARMS Harmonized with the SIPS

    Early Intervention in Psychiatry, Vol. 18, Núm. 4, pp. 255-272

  2. PsyCog: A computerised mini battery for assessing cognition in psychosis

    Schizophrenia Research: Cognition, Vol. 37

2023

  1. A second update on mapping the human genetic architecture of COVID-19

    Nature

  2. Exploring the mediation of DNA methylation across the epigenome between childhood adversity and First Episode of Psychosis—findings from the EU-GEI study

    Molecular Psychiatry, Vol. 28, Núm. 5, pp. 2095-2106

  3. Negative symptoms in children and adolescents with early-onset psychosis and at clinical high-risk for psychosis: systematic review and meta-analysis

    British Journal of Psychiatry, Vol. 31, Núm. 2

  4. Perceived impact of the COVID-19 pandemic on child and adolescent psychiatric services after 1 year (February/March 2021): ESCAP CovCAP survey

    European Child and Adolescent Psychiatry, Vol. 32, Núm. 2, pp. 249-256

  5. Real-world EGFR testing practices for non-small-cell lung cancer by thoracic pathology laboratories across Europe

    ESMO Open, Vol. 8, Núm. 5

  6. Synergistic effects of childhood adversity and polygenic risk in first-episode psychosis: The EU-GEI study

    Psychological Medicine, Vol. 53, Núm. 5, pp. 1970-1978

  7. The association between reasons for first using cannabis, later pattern of use, and risk of first-episode psychosis: the EU-GEI case-control study

    Psychological medicine, Vol. 53, Núm. 15, pp. 7418-7427

  8. The relationship between genetic liability, childhood maltreatment, and IQ: findings from the EU-GEI multicentric case–control study

    Social Psychiatry and Psychiatric Epidemiology, Vol. 58, Núm. 10, pp. 1573-1580

  9. Use of multiple polygenic risk scores for distinguishing schizophrenia-spectrum disorder and affective psychosis categories in a first-episode sample; The EU-GEI study

    Psychological Medicine, Vol. 53, Núm. 8, pp. 3396-3405

2022

  1. Clinical high risk for psychosis paradigm for CAP: do not throw the baby out with the bathwater

    European Child and Adolescent Psychiatry

  2. Consortium neuroscience of attention deficit/hyperactivity disorder and autism spectrum disorder: The ENIGMA adventure

    Human Brain Mapping, Vol. 43, Núm. 1, pp. 37-55

  3. Effects of copy number variations on brain structure and risk for psychiatric illness: Large-scale studies from the ENIGMA working groups on CNVs

    Human Brain Mapping, Vol. 43, Núm. 1, pp. 300-328

2021

  1. Virtual Histology of Cortical Thickness and Shared Neurobiology in 6 Psychiatric Disorders

    JAMA Psychiatry, Vol. 78, Núm. 1, pp. 47-63

2020

  1. Clinical high risk for psychosis model in children and adolescents: a joint position statement of ESCAP Clinical Division and Research Academy

    European Child and Adolescent Psychiatry

  2. Increased power by harmonizing structural MRI site differences with the ComBat batch adjustment method in ENIGMA

    NeuroImage, Vol. 218

  3. Prevention of Psychosis: Advances in Detection, Prognosis, and Intervention

    JAMA Psychiatry, Vol. 77, Núm. 7, pp. 755-765

  4. The Promises and Challenges of Tumor Mutation Burden as an Immunotherapy Biomarker: A Perspective from the International Association for the Study of Lung Cancer Pathology Committee

    Journal of Thoracic Oncology, Vol. 15, Núm. 9, pp. 1409-1424

2019

  1. European college of neuropsychopharmacology network on the prevention of mental disorders and mental health promotion (ECNP PMD-MHP)

    European Neuropsychopharmacology, Vol. 29, Núm. 12, pp. 1301-1311